1. Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients 
Gregory S. Sawicki, Will Chou, Karina Raimundo, Ben Trzaskoma, Michael W. Konstan 
Journal of Cystic Fibrosis 
Volume 14, Issue 6, Pages (November 2015)
DOI: /j.jcf
Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
Study flow. (A) Study design and (B) patient disposition. a4 patients who signed informed consent twice (3 of whom were dispensed a nebulizer and entered the run-in period twice) were each counted twice. b1 patient who was accidently randomly assigned twice was counted twice. This patient was counted as without post-baseline treatment, and also as having completed the study. cIncludes a patient who later re-enrolled.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

3. Fig. S1 PARI eRapid Nebulizer System.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions